Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Non-Muscle Invasive Bladder Neoplasms × Bevacizumab × 90 days × Clear all

Sponsor

Conditions

Colorectal Neoplasms 49 Ovarian Neoplasms 29 Carcinoma, Hepatocellular 24 Neoplasms 16 Carcinoma, Non-Small-Cell Lung 16 Fallopian Tube Neoplasms 15 Colonic Neoplasms 10 Breast Neoplasms 9 Uterine Cervical Neoplasms 8 Liver Neoplasms 8 Rectal Neoplasms 7 Lung Neoplasms 7 Glioblastoma 7 Endometrial Neoplasms 7 Brain Neoplasms 7 Neoplasm Metastasis 6 Triple Negative Breast Neoplasms 5 Stomach Neoplasms 5 Recurrence 5 Carcinoma, Renal Cell 5 Carcinoma, Ovarian Epithelial 5 Small Cell Lung Carcinoma 4 Parkinson Disease 4, Autosomal Dominant Lewy Body 4 Colorectal Cancer Metastatic 4 Advanced Solid Tumors 4 Squamous Cell Carcinoma of Head and Neck 3 Medulloblastoma 3 Gastrointestinal Neoplasms 3 Digestive System Neoplasms 3 Carcinoma, Pancreatic Ductal 3

Interventions

Gemcitabine 8 Mitomycin 5 erdafitinib 4 dodecyl maltoside 4 Cystoscopy 3 Docetaxel 2 BCG Vaccine 2 pirarubicin 1 monalizumab 1 hydroxycamptothecinum 1 durvalumab 1 Transurethral Resection of Bladder 1 Patient Discharge 1 Paclitaxel 1 Magnetic Resonance Spectroscopy 1 Injections 1 Imiquimod 1 Epirubicin 1 Drainage 1 Clinical Trials, Phase II as Topic 1 Clinical Trials, Phase I as Topic 1 Accelerometry 1 5-aminolevulinic acid hexyl ester 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡